7626 - 7650 of 9039 Results
Title
Year
-
OPENTitle: Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 80Issue #: 9Start Page: 969End Page: 969Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2023.2338Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2807607/jamaneurology_erickson_2023_oi_230049_1689611082.26721.pdfCitation Count: 45
-
OPENTitle: American Football Play and Parkinson Disease Among MenJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 6Issue #: 8Start Page: e2328644End Page: e2328644Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2023.28644Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2808207/bruce_2023_oi_230825_1691002545.87841.pdfCitation Count: 28
-
OPENTitle: Is REM Sleep Behavior Disorder Changing? Secular Changes Versus Referral PatternsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 10Start Page: 1519End Page: 1524Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mdc3.13842Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13842Citation Count: 4
- Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study2021RESTRICTEDTitle: Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 1Start Page: 53End Page: 65Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00368-9Citation Count: 67
- Intrepidly studying deep brain stimulation in patients with Parkinson's disease2020RESTRICTEDTitle: Intrepidly studying deep brain stimulation in patients with Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 472End Page: 473Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30138-1Citation Count: 6
- Transdermal Nicotine Treatment and Progression of Early Parkinson’s Disease2023RESTRICTEDTitle: Transdermal Nicotine Treatment and Progression of Early Parkinson’s DiseaseJournal Name: NEJM EvidencePublisher: Massachusetts Medical SocietyVol: 2Issue #: 9Start Page: EVIDoa2200311End Page: EVIDoa2200311Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1056/evidoa2200311Citation Count: 26
-
OPENTitle: Clinical autonomic nervous system laboratories in EuropeJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: 12Start Page: 3633End Page: 3646Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/ene.15538Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15538Citation Count: 24
- Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats2022OPENTitle: Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in ratsJournal Name: Current Research in NeurobiologyPublisher: Elsevier BVVol: 4Issue #:Start Page: 100065End Page: 100065Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.crneur.2022.100065Best OA location URL: https://doi.org/10.1016/j.crneur.2022.100065Citation Count: 21
- Family History for Neurodegeneration in Multiple System Atrophy: Does it Indicate Susceptibility?2022OPENTitle: Family History for Neurodegeneration in Multiple System Atrophy: Does it Indicate Susceptibility?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2310End Page: 2312Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29202Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29202Citation Count: 4
- Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases2022OPENTitle: Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body DiseasesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 10Start Page: 2086End Page: 2098Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29171Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29171Citation Count: 22
- Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease2022OPENTitle: Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2272End Page: 2283Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29193Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29193Citation Count: 38
-
OPENTitle: ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer’s diseaseJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 194End Page: 194Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-022-01119-zBest OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-022-01119-zCitation Count: 20
-
OPENTitle: Dystonia Responsive to Dopamine: POLG Mutations Should Be Considered If Sensory Neuropathy Is PresentJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 14Issue #: 2Start Page: 157End Page: 160Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.20159Best OA location URL: https://doi.org/10.14802/jmd.20159Citation Count: 11
-
OPENTitle: Florbetaben amyloid PET acquisition time: Influence on Centiloids and interpretationJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 8Start Page: 5299End Page: 5310Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.13893Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13893Citation Count: 12
-
OPENTitle: Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l -DOPA–induced dyskinetic behaviorsJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 47Start Page: eadp6301End Page: eadp6301Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.adp6301Best OA location URL: https://doi.org/10.1126/sciadv.adp6301Citation Count: 22
- Conquering Neurologic Diseases in Primary Care2024RESTRICTEDTitle: Conquering Neurologic Diseases in Primary CareJournal Name: Primary Care: Clinics in Office PracticePublisher: Elsevier BVVol: 51Issue #: 2Start Page: xvEnd Page: xviPublication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pop.2024.03.001Citation Count: 0
-
OPENTitle: Valosin-containing-protein pathogenic variant p.R487H in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 10Issue #:Start Page: 100236End Page: 100236Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100236Best OA location URL: http://dx.doi.org/10.1016/j.prdoa.2024.100236Citation Count: 1
-
OPENTitle: Potential sources of interference with the highly sensitive detection and quantification of alpha‐synuclein seeds by qRT‐QuICJournal Name: FEBS Open BioPublisher: WileyVol: 10Issue #: 5Start Page: 883End Page: 893Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/2211-5463.12844Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/2211-5463.12844Citation Count: 15
-
OPENTitle: Predictors of time to initiation of symptomatic therapy in early Parkinson's diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 7Start Page: 482End Page: 494Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.317Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.317Citation Count: 29
-
OPENTitle: Ipsilateral deficits of dopaminergic neurotransmission in Parkinson's diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 1Start Page: 21End Page: 26Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.268Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.268Citation Count: 60
-
OPENTitle: Combining clinical and biofluid markers for early Parkinson's disease detectionJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 5Issue #: 1Start Page: 109End Page: 114Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.509Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.509Citation Count: 13
-
OPENTitle: Imaging analysis of Parkinson’s disease patients using SPECT and tractographyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page: 38070End Page: 38070Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep38070Best OA location URL: https://www.nature.com/articles/srep38070.pdfCitation Count: 41
- Variants in GBA , SNCA , and MAPT influence Parkinson disease risk, age at onset, and progression2015OPENTitle: Variants in GBA , SNCA , and MAPT influence Parkinson disease risk, age at onset, and progressionJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 37Issue #:Start Page: 209.e1End Page: 209.e7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2015.09.014Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2015.09.014Citation Count: 109
- Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease2018OPENTitle: Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 55Issue #:Start Page: 8End Page: 14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.08.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6291234Citation Count: 49
- BKCa nitrosylation is associated with cerebral microvascular dysfunction in female 5x-FAD mice2023RESTRICTEDTitle: BKCa nitrosylation is associated with cerebral microvascular dysfunction in female 5x-FAD miceJournal Name: PhysiologyPublisher: American Physiological SocietyVol: 38Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1152/physiol.2023.38.s1.5731336Citation Count: 0